Physician profile
David Shrock
NPI 1104288679
$2,338.23
in general payments reported to CMS, 2019-2025
19 companies · $335 in 2025
The $335 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $298 · 2022: $651 · 2023: $498 · 2024: $557 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,389.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $392.47 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $372.93 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $339.98 | 2021-2024 | Lokelma, Brilinta, Farxiga |
| Abbvie INC. | $240.22 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $157.73 | 2022-2024 | Verquvo, Dificid |
| Alexion Pharmaceuticals, INC. | $152.16 | 2022-2025 | Ultomiris |
| E.R. Squibb & Sons, L.L.C. | $147.68 | 2021-2024 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $143.63 | 2021-2023 | Jardiance, Stiolto Respimat, Spiriva Respimat |
| Inari Medical, INC. | $73.41 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Enterra Medical, INC. | $67.05 | 2023-2025 | |
| Amgen INC. | $51.55 | 2024-2025 | Evenity, Prolia, Tavneos |
| Viatris Specialty LLC | $43.89 | 2025 | Yupelri |
| Abiomed | $37.06 | 2024 | Impella |
| Medtronic, INC. | $28.16 | 2024 | Linq II |
| Scpharmaceuticals INC. | $22.27 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.78 | 2025 | Xifaxan |
| Mylan Specialty L.P. | $17.32 | 2024 | Yupelri |
| Mallinckrodt Hospital Products INC. | $17.15 | 2024 | Terlivaz |
| Lexicon Pharmaceuticals, INC. | $13.79 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Shrock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.